Buscar
Mostrando ítems 1-10 de 21
The Falling Incidence of Hematologic Cancer After Heart Transplantation
(Wiley, 2014-10-01)
[Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the ...
Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study
(Wiley, 2010-06-27)
[Abstract] The longer survival of patients with heart transplantation (HT) favors calcineurin inhibitor–related chronic kidney disease (CKD). It behoves to identify risk factors. At 14 Spanish centers, data on 1062 adult ...
Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit
(Elsevier, 2020-01-21)
[Abstract] Introduction and objectives: To analyze survival in heart failure (HF) patients treated at a specialized unit.
Methods: Prospective cohort-based study of HF patients treated at a specialized unit from 2011 ...
Safety of statins when response is carefully monitored: a study of 336 heart recipients
(Elsevier, 2005)
[Abstract] Background. Statins are used as first-line drugs against hypercholesterolemia after heart transplantation. Randomized clinical trials have shown that they reduce cholesterol levels, and the incidence of rejection ...
Circulating miR-181a-5p as a New Biomarker for Acute Cellular Rejection in Heart Transplantation
(Elsevier, 2020-06-07)
[Abstract] Background: Acute cellular rejection (ACR) is a major complication in heart transplantation (HTx). Endomyocardial biopsy is the reference method for early detection of ACR, but a new non-invasive approach is ...
Renal dysfunction after orthotopic heart transplantation: incidence, natural history, and risk factors
(Elsevier, 2003-08-30)
[Abstract] Background. Renal dysfunction is a common complication after orthotopic heart transplantation (HT). The importance of factors other than exposure to immunosuppressive drugs is unclear. The purpose of this study ...
Long-term results of heart transplant in recipients older and younger than 65 years: a comparative study of mortality, rejections, and neoplasia in a cohort of 445 patients
(Elsevier, 2005-12-28)
[Resumen] Background. Whether being older than 65 years should be considered an absolute counterindication to heart transplant (HT), as it is in some centers, is controversial. In our centre, patients older than 65 years ...
Hypotension, acidosis and vasodilation syndrome after heart transplant: incidence, risk factors, and prognosis
(Elsevier, 2003-08-30)
[Abstract] Background. HAV syndrome, the combination of hypotension, acidosis and vasodilation (HAV), is a serious postoperative complication after heart transplantation (HT). Its etiology and prognosis are poorly ...